Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
Royalty Pharma plc has appointed Greg Raskin, M.D., as Senior Vice President, Head of Academic Initiatives. Raskin brings nearly 30 years of experience at the intersection of science, medicine, and investing, aimed at deepening Royalty Pharma’s engagement with academic and non-profit institutions and managing the Royalty Pharma Translational Prize.…
Edible Garden AG Incorporated has secured an expanded multi-year supply agreement with a major Midwest big-box retailer, extending their partnership through the end of 2028. The agreement significantly broadens the company's private label fresh herb offerings across the retailer's Midwest footprint. The deal highlights Edible Garden's leadership in…
Alpha Modus Holdings, Inc., through its subsidiary Alpha Cash, announced the launch of the 'Super Connector' ecosystem, a new community-driven model aimed at expanding financial access by partnering with trusted local organizations rather than relying on traditional banking infrastructure. The inaugural ecosystem in Southern California targets onbo…
Northrop Grumman has signed two multi-year framework agreements worth over $3 billion to increase production and speed delivery of key missile defense components, including the PAC-3 MSE solid rocket motors and THAAD system parts. This marks a significant production expansion to meet growing global demand and reinforce U.S. integrated air and missi…
KIDZ AI has signed a Memorandum of Understanding with Limestone Networks to colocate a dedicated NVIDIA Blackwell B300 GPU cluster at Limestone's DFW3 data center in Dallas, Texas. This deployment supports KIDZ AI's 60-month, $44.6 million GPU compute services agreement with Canopy Wave, marking a key step in its neocloud strategy focused on infere…
Candel Therapeutics announced that extended Phase 3 data from their lead immunotherapy candidate, Aglatimagene Besadenovec, will be presented at the 2026 ASTRO Annual Meeting. The company specializes in multimodal biological immunotherapies targeting difficult-to-treat solid tumors, with ongoing clinical trials and several FDA designations supporti…
ExlService Holdings, Inc. announced the completion of its acquisition of iMerit, a leader in AI model training, evaluation, and reinforcement learning. This strategic move combines EXL's data and AI expertise with iMerit's advanced AI capabilities, establishing an end-to-end AI platform aimed at accelerating enterprise AI adoption, particularly in …
Clearmind Medicine, a clinical-stage biotech company listed on Nasdaq, has signed a non-binding Letter of Intent to acquire a 51% majority stake in a company specializing in intelligent wireless EV charging solutions for automated parking and autonomous platforms. The acquisition aims to integrate advanced wireless charging technology to support sm…
POET Technologies Inc., a NASDAQ-listed developer of photonic integrated circuits for AI and data centers, appointed Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, replacing long-serving director Jean-Louis Malinge who resigned. The new appointments bring strong technical and governance expertise as POET advances commercializatio…
Phillips Edison & Company, a leading US owner and operator of grocery-anchored neighborhood shopping centers, has launched an innovative AI-integrated corporate website. This website introduces AI-powered property search functionality, enabling brokers and retailers to use natural language prompts to find ideal retail spaces more efficiently. The i…
Carlsmed announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a reimbursement policy for inpatient aprevo® lumbar spinal fusion procedures under new MS-DRG codes in the FY27 IPPS Final Rule effective October 1, 2026. This reimbursement clarity is expected to expand hospital, surgeon, and patient access to aprevo® procedur…
Neuronetics, Inc. disclosed a constructive agreement with Jorey Chernett, its second largest shareholder, affirming confidence in the company's financial health and management execution. The agreement includes a pathway for board representation, aimed at strengthening shareholder engagement. Major shareholder Madryn Asset Management also reaffirmed…
Swarmer, Inc., a Nasdaq-listed drone autonomy software company, has announced a strategic partnership with Oak Grove Technologies (OGT) to integrate Swarmer's advanced autonomous swarm software with OGT's Chimera unmanned aircraft platform. This collaboration aims to enhance autonomous drone capabilities for U.S. Special Operations Forces, leveragi…
electroCore, Inc., a bioelectronic medicine company, announced its participation in the Needham Virtual MedTech and Diagnostics Conference and the Canaccord Genuity Growth Conference in August 2026, with management presenting and holding one-on-one investor meetings.
Cohen & Company Inc. reported robust financial results for Q2 2026, delivering net income of $3.6 million and adjusted pre-tax income of $10.1 million, both showing significant improvement compared to prior quarters. Driven primarily by their Capital Markets segment and successful SPAC activities, revenue increased to $69.5 million. The company dec…
Mesa Laboratories, Inc., a Nasdaq-listed company specializing in life science tools and quality control solutions, will announce its first quarter fiscal 2027 financial results on August 10, 2026, after market close. The company also plans to hold its inaugural earnings conference call on the same day to discuss financial details and answer analyst…
The Oncology Institute, one of the largest value-based oncology groups in the US, announced its rebranding to Starling Oncology, Inc. alongside a ticker symbol change to STLN on Nasdaq. The rebranding reflects the company's evolution into an integrated oncology platform, emphasizing accessibility, coordinated care, and a mission to address the cost…
Design Therapeutics reports progress in its RESTORE-FA trial with modifications based on positive four-week data, and expects 12-week data in Q1 2027. The company has also initiated dosing in a Phase 1 trial of DT-818 for myotonic dystrophy type 1, and continues development of multiple GeneTAC® programs targeting serious genetic diseases. Financial…
Pelthos Therapeutics Inc., a biopharmaceutical company specializing in cutaneous infectious disease treatments, will report its second quarter 2026 financial results on August 13, 2026, followed by a conference call for investors and analysts. The company focuses on commercializing innovative topical therapies addressing unmet patient needs, includ…
eGain Corporation, recognized as a leader in Gartner's Magic Quadrant for Customer Service Knowledge Management Systems, presented its approach to AI governance emphasizing the importance of an accurate and governed knowledge layer, termed AI KnowledgeOps. Addressing recent AI containment breaches highlighted by OpenAI and Anthropic, eGain position…
Akebia Therapeutics announced the initiation of a Phase 2 basket trial evaluating ebribafusp, a novel complement inhibitor designed to treat rare kidney diseases such as IgA nephropathy, lupus nephritis, and C3 glomerulopathy. The trial aims to demonstrate safety, efficacy, and pharmacokinetics through weekly subcutaneous dosing over 26 weeks, with…
AgEagle Aerial Systems, traded as EagleNXT (NYSE: UAVS), announced the hiring of Lindsay A. Ryan, a 21-year U.S. Army aviation veteran, as Head of Sales and Business Development for their Counter-Unmanned Aircraft Systems (C-UAS) division. Ryan's extensive military experience and leadership in aviation are expected to drive sales growth and expand …
CytomX Therapeutics announced the appointment of Alejandra Carvajal as Chief Legal Officer. With over 20 years of legal expertise in biotech, Ms. Carvajal will aid in the company's strategic and operational initiatives as CytomX advances its oncology-focused PROBODY therapeutic pipeline. The company is focused on conditionally activated biologics f…
Shoals Technologies Group announced a strategic memorandum of understanding with TerraFlow Energy to collaborate on developing and deploying up to 5 GW annually of grid-scale long-duration energy storage, combining TerraFlow's vanadium flow battery technology with Shoals' power distribution systems for utility-scale and data center applications. Th…
Anavex Life Sciences Corp. disclosed plans to refresh its board with two new independent directors possessing deep life sciences and regulatory expertise. The company has established an Executive Committee to manage its business and emphasized focus on advancing its lead Alzheimer's candidate, oral blarcamesine (ANAVEX®2-73), across multiple CNS in…
